Inter Pharma Public Company Limited
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probio… Read more
Market Cap & Net Worth: Inter Pharma Public Company Limited (IP)
Inter Pharma Public Company Limited (BK:IP) has a market capitalization of $73.67 Million (฿2.55 Billion) as of March 19, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #22853 globally and #287 in its home market, demonstrating a 8.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inter Pharma Public Company Limited's stock price ฿4.22 by its total outstanding shares 605344475 (605.34 Million).
Inter Pharma Public Company Limited Market Cap History: 2019 to 2026
Inter Pharma Public Company Limited's market capitalization history from 2019 to 2026. Data shows growth from $45.70 Million to $73.67 Million (2.04% CAGR).
Inter Pharma Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inter Pharma Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Inter Pharma Public Company Limited's market cap is 0.03 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.51x
Inter Pharma Public Company Limited's market cap is 1.51 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $45.70 Million | $371.33 Million | $43.47 Million | 0.12x | 1.05x |
| 2020 | $97.69 Million | $442.10 Million | $52.54 Million | 0.22x | 1.86x |
| 2021 | $204.93 Million | $908.63 Million | $105.22 Million | 0.23x | 1.95x |
| 2022 | $155.54 Million | $1.52 Billion | $118.88 Million | 0.10x | 1.31x |
| 2023 | $96.19 Million | $1.78 Billion | $50.79 Million | 0.05x | 1.89x |
| 2024 | $56.21 Million | $1.90 Billion | $37.28 Million | 0.03x | 1.51x |
Competitor Companies of IP by Market Capitalization
Companies near Inter Pharma Public Company Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Inter Pharma Public Company Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Inter Pharma Public Company Limited Historical Marketcap From 2019 to 2026
Between 2019 and today, Inter Pharma Public Company Limited's market cap moved from $45.70 Million to $ 73.67 Million, with a yearly change of 2.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿73.67 Million | -8.26% |
| 2025 | ฿80.30 Million | +42.86% |
| 2024 | ฿56.21 Million | -41.56% |
| 2023 | ฿96.19 Million | -38.16% |
| 2022 | ฿155.54 Million | -24.10% |
| 2021 | ฿204.93 Million | +109.77% |
| 2020 | ฿97.69 Million | +113.76% |
| 2019 | ฿45.70 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Inter Pharma Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $73.67 Million USD |
| MoneyControl | $73.67 Million USD |
| MarketWatch | $73.67 Million USD |
| marketcap.company | $73.67 Million USD |
| Reuters | $73.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.